| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000024510 |
| Receipt No. | R000028166 |
| Scientific Title | Effect of cereal-derived processed product on metabolism :a randomized, double-blind, crossover study |
| Date of disclosure of the study information | 2016/10/24 |
| Last modified on | 2019/08/26 (Ver. 5) |
| Basic information | ||
| Public title | Effect of cereal-derived processed product on metabolism :a randomized, double-blind, crossover study | |
| Acronym | Effect of cereal-derived processed product on metabolism | |
| Scientific Title | Effect of cereal-derived processed product on metabolism :a randomized, double-blind, crossover study | |
| Scientific Title:Acronym | Effect of cereal-derived processed product on metabolism | |
| Region |
|
|
| Condition | ||
| Condition | healthy humans | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Effect of cereal-derived processed product on metabolism, and clarify its mechanism. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Fat oxidation |
| Key secondary outcomes | Serum glucose-dependent insulinotropic polypeptide and insulin.
Energy expenditure |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of control food (one time) | |
| Interventions/Control_2 | Intake of test food (one time) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. Age<65 of healthy men and menopause women
2. 23<=BMI<30 3. provided written informed consent from subjects |
|||
| Key exclusion criteria | 1; suffering from liver, kidney, heart disease, disorder respiration endocrine, metabolism, nervous system consciousness, diabetes, or other diseases
2; LDL-cholesterol>=140mg/dL, triglyceride>=150mg/dL, Systolic blood pressure>=140mmHg, diastolic pressure>=90mmHg, fasting blood glucose>=126mg/dL, 3; taking medication or operation by severe sickness and injury within 2 months before the trial, 4; becoming unpleasant feeling after blood test or energy expenditure analyzing (metabolic chamber, collecting of breath by mask or hood) 5; making blood donation of 200 mL or more within l month of this trial 6; medicine user for hyperglycemia, hyperlipidemia, or hypertension, 7; unstable measurement of energy expenditure 8; heavy drinker(more than 30 g/day alcohol everyday) 9; user of supplements or foods with health claim 10; having variability in body weight more than +-2.0 kg within 1 month of this trial 11; business trip or travel planned for 5 consecutive days or more during this trial 12; having allergy to gum 13; having allergy to the ingredients included in the test meal 14; smoker 15; participating subject of other clinical study or having a plan during this study period, 16; judged to be inappropriate for the study based on the access record by medical doctor. 17; judged to be inappropriate as subject by physician in charge |
|||
| Target sample size | 15 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Labs | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3 Bunka Sumida-ku Tokyo | ||||||
| TEL | 03-5630-7224 | ||||||
| osaki.noriko@kao.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Labs | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3 Bunka Sumida-ku Tokyo | ||||||
| TEL | 03-5630-7456 | ||||||
| Homepage URL | |||||||
| suzuki.chizuka@kao.co.jp | |||||||
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kao Corporation Human Research IRB |
| Address | 2-1-3 Bunka Sumida-ku Tokyo |
| Tel | +81-3-5630-7263 |
| morisaki.naoko@kao.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | Unpublished due to the protocol including the intellectual property rights |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | works in progress | ||||||
| Number of participants that the trial has enrolled | 22 | ||||||
| Results | Significant difference in the primary outcome |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Healthy subjects |
||||||
| Participant flow | 21 participants completed and 21 subjects were incorporated into the analyses |
||||||
| Adverse events | No adverse effect related to the test diets reported |
||||||
| Outcome measures | Postprandial fat oxidation |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028166 |